彭琬昕,孟凡力,金潔,龔愛華
(1.江蘇大學(xué)基礎(chǔ)醫(yī)學(xué)與醫(yī)學(xué)技術(shù)學(xué)院生物學(xué)系,江蘇鎮(zhèn)江212013;2.南京師范大學(xué)生命科學(xué)院,江蘇南京210023;3.南京醫(yī)科大學(xué)基礎(chǔ)醫(yī)學(xué)院,江蘇南京211166)
Tet-off誘導(dǎo)表達(dá)Egr-1 HEK293穩(wěn)定細(xì)胞株的建立和鑒定
彭琬昕1,2,孟凡力2,3,金潔1,龔愛華1
(1.江蘇大學(xué)基礎(chǔ)醫(yī)學(xué)與醫(yī)學(xué)技術(shù)學(xué)院生物學(xué)系,江蘇鎮(zhèn)江212013;2.南京師范大學(xué)生命科學(xué)院,江蘇南京210023;3.南京醫(yī)科大學(xué)基礎(chǔ)醫(yī)學(xué)院,江蘇南京211166)
目的:利用大腸埃希菌Tet-off誘導(dǎo)表達(dá)調(diào)控系統(tǒng)構(gòu)建多西環(huán)素調(diào)控的穩(wěn)定細(xì)胞株。方法:以pEGFPEgr-1質(zhì)粒為模板,擴(kuò)增含早期生長反應(yīng)蛋白(early growth response-1,Egr-1)完整開放閱讀框的DNA序列,經(jīng)酶切后插入含四環(huán)素反應(yīng)元件(tetracycline responsive element,TRE)序列的表達(dá)載體pTRE2hyg,獲得重組質(zhì)粒pTRE2hyg-Egr-1,將其轉(zhuǎn)染293Tet-off細(xì)胞株,并用G418和多西環(huán)素篩選穩(wěn)定表達(dá)Egr-1的細(xì)胞株。蛋白質(zhì)印跡法檢測多西環(huán)素誘導(dǎo)表達(dá)Egr-1情況;流式細(xì)胞術(shù)檢測細(xì)胞增殖能力。結(jié)果:蛋白質(zhì)印跡結(jié)果顯示,外源性Egr-1蛋白表達(dá)受細(xì)胞培養(yǎng)液中多西環(huán)素調(diào)控,當(dāng)從細(xì)胞培養(yǎng)液中去除多西環(huán)素后,Egr-1表達(dá)量明顯升高。流式細(xì)胞檢測結(jié)果顯示Egr-1高表達(dá)細(xì)胞的增殖能力明顯高于Egr-1低表達(dá)細(xì)胞。結(jié)論:利用Tet-off體系成功構(gòu)建Egr-1誘導(dǎo)表達(dá)的細(xì)胞株,細(xì)胞的增殖能力受Egr-1表達(dá)水平的影響。
Tet-off調(diào)控系統(tǒng);早期生長反應(yīng)蛋白1;穩(wěn)定細(xì)胞株;多西環(huán)素
早期生長反應(yīng)蛋白1(early growth response-1,Egr-1)是具有鋅指結(jié)構(gòu)的核磷酸蛋白,能在多種內(nèi)、外界刺激下迅速表達(dá),例如促有絲分裂原、生長因子、紫外線照射以及損傷等[1]。目前已證實(shí)Egr-1參與胚胎發(fā)育、細(xì)胞生長增殖、分化以及凋亡等多種細(xì)胞事件,多種疾病如炎癥及心血管疾病等與其異常表達(dá)相關(guān)[2-5]。因此,研究Egr-1在細(xì)胞中對下游基因的調(diào)控機(jī)制,可以為多種疾病的基因治療提供理論靶點(diǎn)。本研究旨在利用Tet-off誘導(dǎo)調(diào)控系統(tǒng)建立多西環(huán)素調(diào)控Egr-1基因表達(dá)的293穩(wěn)定細(xì)胞株,為研究Egr-1蛋白功能及其下游信號通路的調(diào)控機(jī)制提供一種有價值的細(xì)胞模型。
1.1 材料
Tet-off誘導(dǎo)表達(dá)系統(tǒng)(Clontech公司)及穩(wěn)定表達(dá)Tet-off質(zhì)粒的HEK293細(xì)胞系(以下稱293Tet-off細(xì)胞系)由南京大學(xué)李朝軍教授實(shí)驗(yàn)室饋贈。Taq DNA聚合酶、T4DNA連接酶、限制性內(nèi)切酶CalⅠ、SalⅠ、CIAP堿性磷酸酶購自TaKaRa公司。DNA片段回收試劑盒、DNA片段PCR純化試劑盒購自Axygen公司,多西環(huán)素和潮霉素B購自Calbiochem公司,一抗Egr-1和β-肌動蛋白購自Santa Cruz公司,羊抗兔HRP二抗購自武漢博士德公司。
1.2 方法
1.2.1 pTRE2hyg-Egr-1引物設(shè)計和目的基因擴(kuò)增
以已構(gòu)建的pEGFP-Egr-1質(zhì)粒為模板,擴(kuò)增含Egr-1完整開放閱讀框的DNA序列。上游引物序列為5′-CCATCGAT(ClaⅠ)ATGGCCGCGGCCAAGGCCGAG-3′;下游引物:5′-CGGAATTC(SalⅠ)TATGGTGGGATGGTGAGGCA-3′。反應(yīng)條件:96℃5 min預(yù)變性,94℃45 s,65℃45 s,72℃120 s,循環(huán)30次,最后再72℃延伸7 min。
1.2.2 重組反應(yīng)質(zhì)粒pTRE2hyg-Egr-1的構(gòu)建、克隆、篩選 PCR產(chǎn)物和含四環(huán)素反應(yīng)元件(tetracycline responsive element,TRE)序列的pTRE2hyg載體使用CalⅠ和SalⅠ分步酶切,1%瓊脂糖凝膠電泳割膠回收,純化DNA。目的基因Egr-1與含相應(yīng)黏性末端的pTRE2hyg連接。
反應(yīng)體系10μL,含10×T4DNA連接酶緩沖液1μL,T4DNA連接酶1 IU,目的基因片段和載體片段按摩爾比3∶1于16℃連接反應(yīng)20 h。連接產(chǎn)物10μL轉(zhuǎn)化入100μL感受態(tài)細(xì)菌DH5α,經(jīng)氨芐西林培養(yǎng)基篩選,重組質(zhì)粒用雙酶切或PCR鑒定后測序分析。
1.2.3 多西環(huán)素抑制EGR-1基因表達(dá)的最佳濃度測定 293Tet-off細(xì)胞株培養(yǎng)于含10%胎牛血清的DMEM中,在37℃,含5%CO2飽和濕度的培養(yǎng)箱中培養(yǎng)。將培養(yǎng)的293Tet-off細(xì)胞系接種于6孔板中,培養(yǎng)至細(xì)胞密度達(dá)60%~70%,按Lipofectamine 2000說明書步驟轉(zhuǎn)染pTRE2hyg-Egr-1重組質(zhì)粒入細(xì)胞,孵育6 h后去除含脂質(zhì)體復(fù)合物的培養(yǎng)基,于37°C、5%CO2培養(yǎng)24 h后進(jìn)行相關(guān)實(shí)驗(yàn)。
按照0,0.5,1,2,4,10,100μg/mL設(shè)定多西環(huán)素的質(zhì)量濃度梯度,分別處理轉(zhuǎn)染了pTRE2hyg-Egr-1質(zhì)粒24 h后的293Tet-off細(xì)胞株,同時將未轉(zhuǎn)染pTRE2hyg-Egr-1質(zhì)粒的293Tet-off細(xì)胞作為陰性對照。藥物處理48 h之后,RAPI裂解細(xì)胞,提取總蛋白。每孔蛋白上樣量30μg,蛋白質(zhì)印跡法檢測Egr-1蛋白的表達(dá)情況,選擇多西環(huán)素抑制Egr-1表達(dá)的最佳濃度。
1.2.4 穩(wěn)定細(xì)胞株的篩選 將293Tet-off細(xì)胞接種至60 mm培養(yǎng)皿中,至密度為70%時轉(zhuǎn)染pTRE2hyg-Egr-1質(zhì)粒。消化細(xì)胞接種至2個10 cm細(xì)胞培養(yǎng)皿,用含200μg/mL G418、10%胎牛血清的DMEM繼續(xù)培養(yǎng)。48 h后,添加潮霉素B至終質(zhì)量濃度為100μg/mL,每兩天換一次液,得到的穩(wěn)定細(xì)胞株命名為293Tet-off-Egr-1。
2.1 重組表達(dá)載體的構(gòu)建及酶切鑒定
人Egr-1全長cDNA以正確的讀碼框插入表達(dá)載體pTRE2hyg中,獲得重組質(zhì)粒pTRE2hyg-Egr-1,質(zhì)粒經(jīng)ClaⅠ、SalⅠ雙酶切得到約1 600 bp的片段(圖1),同預(yù)期的結(jié)果相一致。挑取單個菌落送上海生工生物公司進(jìn)行序列測序,結(jié)果完全正確。
圖1 重組表達(dá)載體pTRE2hyg-Egr-1酶切鑒定
2.2 多西環(huán)素負(fù)調(diào)控Egr-1蛋白表達(dá)的測定
將不同質(zhì)量濃度多西環(huán)素(0、0.5、1、2、4、10、100μg/mL)處理的293Tet-off-Egr-1細(xì)胞以及293Tet-off對照組細(xì)胞裂解液加入6×上樣緩沖液,10%SDSPAGE電泳,轉(zhuǎn)至PVDF上,檢測Egr-1蛋白表達(dá),以β-肌動蛋白作為內(nèi)參。實(shí)驗(yàn)結(jié)果顯示(圖2),在80 000左右位置檢測到Egr-1蛋白,培養(yǎng)液中未加多西環(huán)素時(0μg/mL),293Tet-off-Egr-1細(xì)胞能有效表達(dá)外源性Egr-1蛋白;隨著濃度的加大,多西環(huán)素對Egr-1表達(dá)的抑制作用逐漸增強(qiáng)。當(dāng)多西環(huán)素的濃度達(dá)到10μg/mL時,與未加多西環(huán)素處理組相比,Egr-1水平明顯降低。
圖2 蛋白質(zhì)印跡法檢測293Tet-off-Egr-1細(xì)胞中Egr-1蛋白的表達(dá)
2.3 Egr-1對細(xì)胞增殖能力的影響
利用我們建立的293Tet-off-Egr-1細(xì)胞模型檢測Egr-1不同表達(dá)量情況下細(xì)胞周期的變化情況。結(jié)果顯示,Egr-1高表達(dá)的293Tet-off-Egr-1細(xì)胞(0、1μg/mL多西環(huán)素處理組)S期細(xì)胞所占的比例明顯高于加入了20μg/mL多西環(huán)素的細(xì)胞組(圖3)。
圖3 不同濃度多西環(huán)素處理后細(xì)胞周期的變化
Tet-off誘導(dǎo)表達(dá)系統(tǒng)是20世紀(jì)90年代以來Gossen等[6-8]利用大腸埃希菌轉(zhuǎn)座子Tn10四環(huán)素抗性操縱子創(chuàng)建的一種高效、嚴(yán)密并特異地控制外源基因表達(dá)的體系。通過加入四環(huán)素或其衍生物多西環(huán)素能抑制目的基因的表達(dá),而在去除培養(yǎng)基中的四環(huán)霉素或多西環(huán)素后目的基因的表達(dá)被激活[9]。隨著細(xì)胞培養(yǎng)基中四環(huán)素或多西環(huán)素減少,外源基因表達(dá)逐漸增加,且表達(dá)按照一種劑量依賴方式受四環(huán)素或者多西環(huán)素精準(zhǔn)調(diào)控[10]。Tet-off系統(tǒng)主要包括2個部分,即調(diào)節(jié)質(zhì)粒和反應(yīng)質(zhì)粒。調(diào)節(jié)質(zhì)粒可以表達(dá)一種融合蛋白,稱為四環(huán)素反應(yīng)轉(zhuǎn)錄活化因子(tTA);反應(yīng)質(zhì)粒含有四環(huán)素反應(yīng)元件[11]。本實(shí)驗(yàn)中,我們將Egr-1基因插入pTRE載體中反應(yīng)原件TRE的下游,并將該重組質(zhì)粒轉(zhuǎn)染含有pTet-off基因的293穩(wěn)定細(xì)胞株,得到受四環(huán)素及其衍生物多西環(huán)素調(diào)控Egr-1蛋白表達(dá)的穩(wěn)定細(xì)胞株293Tet-off-Egr-1。
Egr-1又稱NFGI-A、Zif268、Krox24和TIS8等,能被一系列生長因子、細(xì)胞因子和損傷刺激迅速而瞬時地誘導(dǎo)表達(dá)[12-13]。Egr-1參與多種細(xì)胞進(jìn)程,其中包括血管發(fā)生、腫瘤發(fā)生、缺血應(yīng)激、損傷愈合和一些血管疾病[14-15]。Egr-1在體內(nèi)正常組織和細(xì)胞中表達(dá)極低,甚至不表達(dá);而在生長活躍器官或組織的細(xì)胞中表達(dá)明顯增多。已有文獻(xiàn)報道,Egr-1通過直接或間接地參與細(xì)胞增殖、凋亡、分化等過程,在腫瘤形成和心血管、肺臟、腎臟等系統(tǒng)的疾病中發(fā)揮重要作用[16-17]。
本實(shí)驗(yàn)中我們成功構(gòu)建了Tet-off基因表達(dá)系統(tǒng)反應(yīng)質(zhì)粒pTRE2hyg-Egr-1。初步結(jié)果顯示,反應(yīng)質(zhì)粒pTRE2hyg-Egr-1轉(zhuǎn)染至293Tet-off細(xì)胞后,在多西環(huán)素的存在下,Egr-1蛋白表達(dá)水平隨多西環(huán)素質(zhì)量濃度升高而下調(diào)。與未加多西環(huán)素處理的對照組相比,實(shí)驗(yàn)組Egr-1表達(dá)量明顯下降。流式細(xì)胞檢測結(jié)果顯示,在不同濃度多西環(huán)素存在情況下,隨著Egr-1表達(dá)量的不同,293Tet-off細(xì)胞的周期發(fā)生明顯改變,證明該細(xì)胞株可以作為研究Egr-1對細(xì)胞行為調(diào)控作用的實(shí)驗(yàn)工具。
[1] Baron V,De GG,Krones-Herzig A,et al.Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo[J].Oncogene,2003,22(27):4194-4204.
[2] Kinehara M,Kawamura S,Mimura S,et al.Protein kinase C-induced early growth response protein-1 binding to SNAIL promoter in epithelial-mesenchymal transition of human embryonic stem cells[J].Stem Cells Dev,2014.[Epub ahead of print]
[3] Adamson ED,Mercola D.Egr1 transcription factor:mul-tiple roles in prostate tumor cell growth and survival[J].Tumor Biol,2002,23(2):93-102.
[4] Liu C,Rangnekar VM,Adamson E,et al.Suppression of growth and transformation and induction of apoptosis by Egr-1[J].Cancer Gene Ther,1998,5(1):3-28.
[5] Thiel G,Cibelli G.Regulation of life and death by the zinc finger transcription factor Egr-1[J].JCell Physiol,2002,193(3):287-292.
[6] Gossen M,Bujard H.Tight control of gene expression in mammalian cells by tetracycline-responsive promoters[J].Proc Natl Acad Sci,1992,89(12):5547-5551.
[7] 楊春燕,劉佳,錢其軍,等.一種新型的Tet-off慢病毒調(diào)控系統(tǒng)的構(gòu)建及其調(diào)控作用[J].浙江理工大學(xué)學(xué)報,2010,5(27):805-809.
[8] Gossen M,F(xiàn)reundlieb S,Bender G,etal.Transcriptional activation by tetracyclines in mammalian cells[J].Science,1995,268(5218):1766-1769.
[9] 蘆小燕,解慧琪,鄧力,等.Tet基因表達(dá)調(diào)控系統(tǒng)及其應(yīng)用[J].中國醫(yī)藥生物技術(shù),2007,4(2):303-306.
[10] 徐宗全,陳孝平,張萬廣,等,Tet-on基因表達(dá)系統(tǒng)反應(yīng)質(zhì)粒pTRE-HIF-1α的構(gòu)建和表達(dá)鑒定[J].中國普外基礎(chǔ)與臨床雜志,2008,12(15):887-891.
[11] Lee YB,Glover CP,Cosgrave A,et al.Optimizing regulatable gene expression using adenoviral vectors[J].J Exp Physiol,2005,90(1):33-37.
[12] Ehrengruber MU,Muhlebach SG,Sohrman S,et al.Modulation of early growth response(EGR)transcription factor-dependent gene expression by using recombinant adenovirus[J].Gene,2000,258(1/2):63-69.
[13] Sukhatme VP,Cao XM,Chang LC,et al.A zinc fingerencoding gene coregulated with c-fos during growth and differentiation,and after cellular depolarization[J].Cell,1988,53(1):37-43.
[14] Pavletich NP,Pabo CO.Zinc finger-DNA recognition:crystal structure of a Zif268-DNA complex at2.1A[J].Science,1991,252(5007):809-817.
[15] Mitchell A,Dass CR,Sun LQ,et al.Inhibition of human breast carcinoma proliferation,migration,chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1[J].Nucleic Acids Res,2004,32(10):3065-3069.
[16] Rockel JS,Bernier SM,Leask A.Egr-1 inhibits the expression of extracellularmatrix genes in chondrocytes by TNF-αinduced MEK/ERK signaling[J].Arthritis Res Ther,2009,11(1):1-14.
[17] Khachigian LM.Early growth response-1 in cardiovascular pathobiology[J].Circ Res,2006,98(2):186-191.
Establishment and detection of a Tet-off stable cell line expressing Egr-1 protein regulated by doxycycline
PENGWan-xin1,2,MENG Fan-li2,3,JIN Jie1,GONG Ai-hua1
(1.Department of Biology,School of Medical Science and Laboratory Medicine,Jiangsu University,Zhenjiang Jiangsu 212013;2.School of life science,Nanjing Normal University,Nanjing Jiangsu 210023;3.School of Basic Medical Sciences,Nanjing Medical University,Nanjing Jiangsu 211166,China)
Objective:To construct the responsive plasmid of pTRE2hyg-Egr-1 Tet-off gene expression system and examine its expression.M ethods:PCR was performed to obtain the cDNA of early growth response-1(Egr-1)which was inserted into the responsive plasmid PTRE2hyg.DNA sequencing was performed after the recombinant of responsive plasmid pTRE2hyg-Egr-1 was identified by sequencing.This recombinant vector was transfected into 293Tet-offcells by means of liposome and its expression was examined by Western blotting under the control of deoxycycline.Results:The responsive plasmid pTRE2hyg-Egr-1 verified by sequencing,was capable of expression in 293Tet-offcould be controlled by deoxycycline concentration.Conclusion:The responsive plasmid pTRE2hyg-Egr-1 of Tet-off expression system was constructed successfully,and it can express under the regulation of deoxycycline in the 293Tet-offcells.
Tet-off inducible gene expression system;early growth response-1;stable cell line;doxycycline
R329.28
A
1671-7783(2014)02-0118-04
10.13312/j.issn.1671-7783.y140046
國家自然科學(xué)基金資助項(xiàng)目(31100964)
彭琬昕(1982—),女,安徽合肥人,講師,主要從事腫瘤細(xì)胞生物學(xué)研究。
2014-03-04 [編輯]陳海林